Cochlear cops an earbashing

Product recalls, market share losses, bungled product launches and margin pressures. James Carlisle wonders whether this time Cochlear will bounce back.

How are the mighty fallen. It’s been a good ride since bionic ear manufacturer Cochlear first listed on the ASX back in 1995, with the stock gaining about 19% a year on average. But it has had some extreme setbacks.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles